The Abrysvo vaccine protects against respiratory syncytial virus (RSV), a common pathogen that can cause severe illness, especially in older adults and infants. The cost of Abrysvo can vary significantly depending on several factors. Understanding these variables is key to navigating the financial aspects of vaccination.
Understanding the Base Cost and Influencing Factors
The cash price for Abrysvo without insurance typically ranges from $300 to $550. Specific prices have been observed from approximately $307.58 to $482.68, with an average retail price around $350. This represents the vaccine’s cost before any insurance coverage or discounts.
Several factors influence this base cost. The specific healthcare provider, such as a pharmacy or doctor’s office, can affect the price. Regional pricing differences also play a role, meaning costs can vary by state or city. Additionally, the administration fee may be bundled into the overall price or charged separately, impacting the total out-of-pocket expense.
Insurance Coverage and Your Out-of-Pocket Expense
Insurance coverage can significantly reduce the amount an individual pays for the Abrysvo vaccine. Many private insurance plans typically cover it, especially since it is recommended by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP). The exact out-of-pocket cost depends on your plan’s specifics, including deductibles, copays, coinsurance, and whether the provider is in-network.
For Medicare enrollees, Abrysvo is covered under Medicare Part D. The Inflation Reduction Act (IRA) eliminated cost-sharing for ACIP-recommended adult vaccines, meaning most beneficiaries pay $0.
Medicaid coverage varies by state, but the IRA mandates coverage without cost-sharing for nearly all full-benefit adult Medicaid beneficiaries when ACIP recommendations apply. Pregnant individuals under 19 may receive the vaccine through the Vaccines for Children (VFC) program. Always contact your insurance provider to confirm specific coverage details and potential costs.
Finding Affordable Access to the Abrysvo Vaccine
Several strategies can help individuals find more affordable access to the Abrysvo vaccine. Manufacturer patient assistance programs, such as Pfizer RxPathways, may offer discounted or free vaccines to eligible uninsured or underinsured individuals. Eligibility for these programs often depends on income levels and residency requirements.
Discount coupons and savings cards from various platforms can also significantly lower the price, with some reducing the cost to a range from under $200 to over $300. These coupons are often accepted at major pharmacy chains. Local health departments and public health clinics may also offer vaccines at reduced or no cost. Comparing prices between different pharmacies or healthcare providers and inquiring about all potential costs, including administration fees, before vaccination can help secure the best available price.